(NASDAQ: BBLG) Bone Biologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 66.58%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 61.64%.
Bone Biologics's earnings in 2025 is -$7,353,094.On average, 1 Wall Street analyst forecast BBLG's earnings for 2025 to be -$4,803,891, with the lowest BBLG earnings forecast at -$4,803,891, and the highest BBLG earnings forecast at -$4,803,891.
In 2026, BBLG is forecast to generate -$4,853,162 in earnings, with the lowest earnings forecast at -$4,853,162 and the highest earnings forecast at -$4,853,162.